sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Monoclonal antibodies (mAbs) Biosimilars Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Monoclonal antibodies (mAbs) Biosimilars Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :90
Published Date : 2020-12-28

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Monoclonal antibodies mAbs Biosimilars Market with our analysts monitoring the situation across the globe.
Monoclonal antibodies (mAbs) Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal antibodies (mAbs) Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2027. The key players covered in this study Biocon Celltrion Dr. Reddy's Laboratories Hospira 3SBio Accord Healthcare AET Biotech Allergan Amega Biotech Others Market segment by Type, the product can be split into Erythropoietin (EPO) Human Growth Hormone (HGH) Granulocyte- Colony Stimulating Factor (G-CSF) Monoclonal Antibody (mAb) Insulin Interferon (IFN) Others Market segment by Application, split into Anti-Cancer Anti-Inflammatory/Autoimmune Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Monoclonal antibodies (mAbs) Biosimilars Revenue 1.4 Market by Type 1.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type: 2021 VS 2027 1.4.2 Erythropoietin (EPO) 1.4.3 Human Growth Hormone (HGH) 1.4.4 Granulocyte- Colony Stimulating Factor (G-CSF) 1.4.5 Monoclonal Antibody (mAb) 1.4.6 Insulin 1.4.7 Interferon (IFN) 1.4.8 Others 1.5 Market by Application 1.5.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2021 VS 2027 1.5.2 Anti-Cancer 1.5.3 Anti-Inflammatory/Autoimmune 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Perspective (2015-2027) 2.2 Global Monoclonal antibodies (mAbs) Biosimilars Growth Trends by Regions 2.2.1 Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions: 2015 VS 2021 VS 2027 2.2.2 Monoclonal antibodies (mAbs) Biosimilars Historic Market Share by Regions (2015-2021) 2.2.3 Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Regions (2021-2027) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Monoclonal antibodies (mAbs) Biosimilars Market Growth Strategy 2.3.6 Primary Interviews with Key Monoclonal antibodies (mAbs) Biosimilars Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Market Size 3.1.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue (2015-2021) 3.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Players (2015-2021) 3.1.3 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio 3.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2019 3.3 Monoclonal antibodies (mAbs) Biosimilars Key Players Head office and Area Served 3.4 Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service 3.5 Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2027) 4.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Type (2015-2021) 4.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2021-2027) 5 Market Size by Application (2015-2027) 5.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) 5.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2021-2027) 6 North America 6.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2021) 6.2 Monoclonal antibodies (mAbs) Biosimilars Key Players in North America (2019-2021) 6.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) 6.4 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) 7 Europe 7.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2021) 7.2 Monoclonal antibodies (mAbs) Biosimilars Key Players in Europe (2019-2021) 7.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) 7.4 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) 8 China 8.1 China Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2021) 8.2 Monoclonal antibodies (mAbs) Biosimilars Key Players in China (2019-2021) 8.3 China Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) 8.4 China Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) 9 Japan 9.1 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2021) 9.2 Monoclonal antibodies (mAbs) Biosimilars Key Players in Japan (2019-2021) 9.3 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) 9.4 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) 10 Southeast Asia 10.1 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2021) 10.2 Monoclonal antibodies (mAbs) Biosimilars Key Players in Southeast Asia (2019-2021) 10.3 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) 10.4 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) 11 India 11.1 India Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2021) 11.2 Monoclonal antibodies (mAbs) Biosimilars Key Players in India (2019-2021) 11.3 India Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) 11.4 India Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) 12 Central & South America 12.1 Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Size (2015-2021) 12.2 Monoclonal antibodies (mAbs) Biosimilars Key Players in Central & South America (2019-2021) 12.3 Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) 12.4 Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) 13 Key Players Profiles 13.1 Biocon 13.1.1 Biocon Company Details 13.1.2 Biocon Business Overview 13.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Introduction 13.1.4 Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021)) 13.1.5 Biocon Recent Development 13.2 Celltrion 13.2.1 Celltrion Company Details 13.2.2 Celltrion Business Overview 13.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Introduction 13.2.4 Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.2.5 Celltrion Recent Development 13.3 Dr. Reddy's Laboratories 13.3.1 Dr. Reddy's Laboratories Company Details 13.3.2 Dr. Reddy's Laboratories Business Overview 13.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Introduction 13.3.4 Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.3.5 Dr. Reddy's Laboratories Recent Development 13.4 Hospira 13.4.1 Hospira Company Details 13.4.2 Hospira Business Overview 13.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Introduction 13.4.4 Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.4.5 Hospira Recent Development 13.5 3SBio 13.5.1 3SBio Company Details 13.5.2 3SBio Business Overview 13.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Introduction 13.5.4 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.5.5 3SBio Recent Development 13.6 Accord Healthcare 13.6.1 Accord Healthcare Company Details 13.6.2 Accord Healthcare Business Overview 13.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Introduction 13.6.4 Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.6.5 Accord Healthcare Recent Development 13.7 AET Biotech 13.7.1 AET Biotech Company Details 13.7.2 AET Biotech Business Overview 13.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction 13.7.4 AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.7.5 AET Biotech Recent Development 13.8 Allergan 13.8.1 Allergan Company Details 13.8.2 Allergan Business Overview 13.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Introduction 13.8.4 Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.8.5 Allergan Recent Development 13.9 Amega Biotech 13.9.1 Amega Biotech Company Details 13.9.2 Amega Biotech Business Overview 13.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction 13.9.4 Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.9.5 Amega Biotech Recent Development 13.10 Others 13.10.1 Others Company Details 13.10.2 Others Business Overview 13.10.3 Others Monoclonal antibodies (mAbs) Biosimilars Introduction 13.10.4 Others Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) 13.10.5 Others Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. Monoclonal antibodies (mAbs) Biosimilars Key Market Segments Table 2. Key Players Covered: Ranking by Monoclonal antibodies (mAbs) Biosimilars Revenue Table 3. Ranking of Global Top Monoclonal antibodies (mAbs) Biosimilars Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type (US$ Million): 2021 VS 2027 Table 5. Key Players of Erythropoietin (EPO) Table 6. Key Players of Human Growth Hormone (HGH) Table 7. Key Players of Granulocyte- Colony Stimulating Factor (G-CSF) Table 8. Key Players of Monoclonal Antibody (mAb) Table 9. Key Players of Insulin Table 10. Key Players of Interferon (IFN) Table 11. Key Players of Others Table 12. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth by Application (US$ Million): 2021 VS 2027 Table 13. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (US$ Million): 2021 VS 2027 Table 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (2015-2021) (US$ Million) Table 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2015-2021) Table 16. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Regions (2021-2027) (US$ Million) Table 17. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2021-2027) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Monoclonal antibodies (mAbs) Biosimilars Market Growth Strategy Table 22. Main Points Interviewed from Key Monoclonal antibodies (mAbs) Biosimilars Players Table 23. Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Players (2015-2021) (Million US$) Table 24. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players (2015-2021) Table 25. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2019) Table 26. Global Monoclonal antibodies (mAbs) Biosimilars by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service Table 29. Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) (Million US$) Table 32. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Type (2015-2021) Table 33. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2021-2027) Table 34. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Application (2015-2021) Table 35. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) (Million US$) Table 36. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Application (2021-2027) Table 37. North America Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue (2019-2021) (Million US$) Table 38. North America Key Players Monoclonal antibodies (mAbs) Biosimilars Market Share (2019-2021) Table 39. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) (Million US$) Table 40. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2021) Table 41. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) (Million US$) Table 42. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2021) Table 43. Europe Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue (2019-2021) (Million US$) Table 44. Europe Key Players Monoclonal antibodies (mAbs) Biosimilars Market Share (2019-2021) Table 45. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) (Million US$) Table 46. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2021) Table 47. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) (Million US$) Table 48. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2021) Table 49. China Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue (2019-2021) (Million US$) Table 50. China Key Players Monoclonal antibodies (mAbs) Biosimilars Market Share (2019-2021) Table 51. China Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) (Million US$) Table 52. China Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2021) Table 53. China Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) (Million US$) Table 54. China Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2021) Table 55. Japan Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue (2019-2021) (Million US$) Table 56. Japan Key Players Monoclonal antibodies (mAbs) Biosimilars Market Share (2019-2021) Table 57. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) (Million US$) Table 58. Japan Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2021) Table 59. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) (Million US$) Table 60. Japan Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2021) Table 61. Southeast Asia Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue (2019-2021) (Million US$) Table 62. Southeast Asia Key Players Monoclonal antibodies (mAbs) Biosimilars Market Share (2019-2021) Table 63. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) (Million US$) Table 64. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2021) Table 65. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) (Million US$) Table 66. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2021) Table 67. India Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue (2019-2021) (Million US$) Table 68. India Key Players Monoclonal antibodies (mAbs) Biosimilars Market Share (2019-2021) Table 69. India Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) (Million US$) Table 70. India Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2021) Table 71. India Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) (Million US$) Table 72. India Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2021) Table 73. Central & South America Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue (2019-2021) (Million US$) Table 74. Central & South America Key Players Monoclonal antibodies (mAbs) Biosimilars Market Share (2019-2021) Table 75. Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2021) (Million US$) Table 76. Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2015-2021) Table 77. Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2021) (Million US$) Table 78. Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2015-2021) Table 79. Biocon Company Details Table 80. Biocon Business Overview Table 81. Biocon Product Table 82. Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 83. Biocon Recent Development Table 84. Celltrion Company Details Table 85. Celltrion Business Overview Table 86. Celltrion Product Table 87. Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 88. Celltrion Recent Development Table 89. Dr. Reddy's Laboratories Company Details Table 90. Dr. Reddy's Laboratories Business Overview Table 91. Dr. Reddy's Laboratories Product Table 92. Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 93. Dr. Reddy's Laboratories Recent Development Table 94. Hospira Company Details Table 95. Hospira Business Overview Table 96. Hospira Product Table 97. Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 98. Hospira Recent Development Table 99. 3SBio Company Details Table 100. 3SBio Business Overview Table 101. 3SBio Product Table 102. 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 103. 3SBio Recent Development Table 104. Accord Healthcare Company Details Table 105. Accord Healthcare Business Overview Table 106. Accord Healthcare Product Table 107. Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 108. Accord Healthcare Recent Development Table 109. AET Biotech Company Details Table 110. AET Biotech Business Overview Table 111. AET Biotech Product Table 112. AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 113. AET Biotech Recent Development Table 114. Allergan Business Overview Table 115. Allergan Product Table 116. Allergan Company Details Table 117. Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 118. Allergan Recent Development Table 119. Amega Biotech Company Details Table 120. Amega Biotech Business Overview Table 121. Amega Biotech Product Table 122. Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 123. Amega Biotech Recent Development Table 124. Others Company Details Table 125. Others Business Overview Table 126. Others Product Table 127. Others Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2015-2021) (Million US$) Table 128. Others Recent Development Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Type: 2021 VS 2027 Figure 2. Erythropoietin (EPO) Features Figure 3. Human Growth Hormone (HGH) Features Figure 4. Granulocyte- Colony Stimulating Factor (G-CSF) Features Figure 5. Monoclonal Antibody (mAb) Features Figure 6. Insulin Features Figure 7. Interferon (IFN) Features Figure 8. Others Features Figure 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2021 VS 2027 Figure 10. Anti-Cancer Case Studies Figure 11. Anti-Inflammatory/Autoimmune Case Studies Figure 12. Monoclonal antibodies (mAbs) Biosimilars Report Years Considered Figure 13. Global Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth 2015-2027 (US$ Million) Figure 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions: 2021 VS 2027 Figure 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2021-2027) Figure 16. Porter's Five Forces Analysis Figure 17. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players in 2019 Figure 18. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2019 Figure 20. North America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2021) (Million US$) Figure 21. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2021) (Million US$) Figure 22. China Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2021) (Million US$) Figure 23. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2021) (Million US$) Figure 24. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2021) (Million US$) Figure 25. India Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2021) (Million US$) Figure 26. Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2015-2021) (Million US$) Figure 27. Bottom-up and Top-down Approaches for This Report Figure 28. Data Triangulation Figure 29. Key Executives Interviewed

Get Free Sample

Related Reports

Global Monoclonal antibodies (mAbs) Biosimilars Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Monoclonal antibodies (mAbs) Biosimilars Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Monoclonal antibodies (mAbs) Biosimilars Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Monoclonal antibodies (mAbs) Biosimilars Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Monoclonal antibodies (mAbs) Biosimilars Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)